ContraFect (United States)

Recent papers from ContraFect (United States)

1. Training caregivers to deliver accurate learn units: collateral effects on communication in toddlers with developmental delays across settingsTizard Learning Disability Review · 2026
2. Beyond the facts: building fluency in word problem solvingTizard Learning Disability Review · 2026
3. Digital Twin-Enabled Business Innovation Within and Beyond the Firm: A Systematic Literature Review and Innovation TypologySystems · 2026
4. Extending CABAS® components to reading and mathematics: making text speak and math verbalTizard Learning Disability Review · 2026
5. The effects of Do-See correspondence training on toddler and preschooler’s imitation repertoireTizard Learning Disability Review · 2026
6. The Effects of Peers Versus Adults on Observational Conditioning‐By‐DenialBehavioral Interventions · 2026
7. Using AI to support accurate measurement of ABA instruction: a proof-of-concept demonstrationTizard Learning Disability Review · 2026
8. Evaluating the efficiency of behavioural skills training and the teacher performance rate and accuracy measureTizard Learning Disability Review · 2026
9. A preliminary analysis of stimulus class on skill acquisitionTizard Learning Disability Review · 2026
10. The effects of peer tutoring on the acquisition of new operants for tutors, tutees and observersTizard Learning Disability Review · 2026
11. In vitro exebacase (CF-301) activity against methicillin-susceptible or methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci strains isolated from patients with infective endocarditisJournal of Antimicrobial Chemotherapy · 2025
12. Methodology of a Social Network Survey in Primary Care Practices With Medical Home AttributesJournal of Ambulatory Care Management · 2025
13. The Engineered Lysin CF-370 Is Active Against Antibiotic-Resistant Gram-Negative Pathogens In Vitro and Synergizes With Meropenem in Experimental Pseudomonas aeruginosa PneumoniaThe Journal of Infectious Diseases · 2024
14. Exebacase in Addition to Standard-of-Care Antibiotics for Staphylococcus aureus Bloodstream Infections and Right-Sided Infective Endocarditis: A Phase 3, Superiority-Design, Placebo-Controlled, Randomized Clinical Trial (DISRUPT)Clinical Infectious Diseases · 2024
15. Rapid bacteriolysis of Staphylococcus aureus by lysin exebacaseMicrobiology Spectrum · 2023
16. In vitro activity of exebacase against methicillin-resistant Staphylococcus aureus biofilms on orthopedic Kirschner wiresBMC Research Notes · 2023
17. What does anthropology have to say about misogyny?International Journal of Applied Psychoanalytic Studies · 2023
18. The Lysin Exebacase Has a Low Propensity for Resistance Development in Staphylococcus aureus and Suppresses the Emergence of Resistance to Antistaphylococcal AntibioticsMicrobiology Spectrum · 2023
19. Locally delivered antistaphylococcal lysin exebacase or CF-296 is active in methicillin-resistant Staphylococcus aureus implant-associated osteomyelitisJournal of Bone and Joint Infection · 2022
20. Activity of Exebacase (CF-301) against Biofilms Formed by Staphylococcus epidermidis Strains Isolated from Prosthetic Joint InfectionsAntimicrobial Agents and Chemotherapy · 2022